mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.2 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.3 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.3 |